secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIORA THERAPEUTICS, INC. (—)
CIK:        0001580063
Form:       8-K
Filed at:   2024-03-11T23:59:59+00:00
Accession:  0001193125-24-064362
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biora cuts debt via $5.6M note exchange; monetizes Enumera stake for $3M
------------------------------------------------------------------------

- Exchanged $5.6M of 7.25% 2025 notes for $3.8M of 11%/13% 2028 secured notes with Context Capital.
- Context Capital also purchased $2.8M of 2028 notes and warrants for 2M shares at $2.75 exercise price.
- Sold minority stake in Enumera Molecular for $3.0M nondilutive cash.
- Since Sept 2023, reduced debt by over $80M and raised $19.8M in three exchange transactions.
- Warrants exercisable from Sep 12, 2024 to Mar 12, 2029; 9.9% beneficial ownership cap.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580063/000119312524064362/0001193125-24-064362-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580063/000119312524064362/d772643d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-064362

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer